Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
McKinsey
Healthtrust
AstraZeneca
Cipla
Dow
Merck
Cantor Fitzgerald
Chinese Patent Office

Generated: October 18, 2017

DrugPatentWatch Database Preview

Quantum Pharmics Company Profile

« Back to Dashboard

What is the competitive landscape for QUANTUM PHARMICS, and what generic and branded alternatives to QUANTUM PHARMICS drugs are available?

QUANTUM PHARMICS has sixty-three approved drugs.



Summary for Applicant: Quantum Pharmics

US Patents:0
Tradenames:25
Ingredients:23
NDAs:63
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL071980-001Apr 17, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL088551-001Oct 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
CLOPRA
metoclopramide hydrochloride
TABLET;ORAL072384-001Jun 2, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL088514-001Jan 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
BENZTROPINE MESYLATE
benztropine mesylate
TABLET;ORAL088511-001Jan 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
HYDRALAZINE HYDROCHLORIDE
hydralazine hydrochloride
TABLET;ORAL088671-001May 1, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
ZAXOPAM
oxazepam
CAPSULE;ORAL070641-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
Q-PAM
diazepam
TABLET;ORAL070424-001Dec 12, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
ZAXOPAM
oxazepam
CAPSULE;ORAL070650-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum Pharmics
MECLODIUM
meclofenamate sodium
CAPSULE;ORAL071381-001Jul 14, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Baxter
Farmers Insurance
Colorcon
QuintilesIMS
Federal Trade Commission
US Department of Justice
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot